Francesco Galimi - 18 Mar 2026 Form 3 Insider Report for Genenta Science S.p.A. (GNTA)

Role
CMO & Head of Development, Director
Signature
/s/ Francesco Galimi
Issuer symbol
GNTA
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 16:08:35 UTC
Previous filing
07 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Galimi Francesco CMO & Head of Development, Director 12930 VIA ESPERIA, DEL MAR, /s/ Francesco Galimi 18 Mar 2026 0001823996

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GNTA Ordinary Shares 0 18 Mar 2026 Direct
holding GNTA American Depositary Shares ("ADSs") 0 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GNTA Stock Option (right to buy) 18 Mar 2026 ADSs 20,000 $4.36 Direct F2
holding GNTA Stock Option (right to buy) 18 Mar 2026 ADSs 27,110 $2.57 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents one ordinary share, no par value, of the Issuer.
F2 The stock options vest in equal monthly installments over one year beginning June 4, 2025.
F3 The stock options vested in three equal monthly installments beginning November 1, 2025, and are now fully vested.